Despite underperforming the market over the past year, Medtronic still enjoys fairly upbeat outlook from analysts.

The pharma company's newer immunology drugs, Skyrizi and Rinvoq, have delivered robust sales growth that's proving to be the ...

A Medtronic hypertension procedure that can provide last-resort treatment for a condition that affects nearly half of all U.S ...

Medtronic (NYSE: MDT) announced that Gregory L. Smith, EVP, enterprise operations, notified the company of his decision to ...

Press Release  Medical technology leader, Medtronic has successfully concluded the UK leg of its European ACM2U Truck ...

On August 19th, Medtronic released its earnings report for the fiscal first quarter ended July 25th, 2025. The company's ...

National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained ...

An announcement from Medtronic ( ($MDT) ) is now available. On November 1, 2025, Medtronic announced the retirement of Gregory L. Smith, Executive ...

Intuitive Surgical (ISRG 0.81%) has dominated the market for robotic-assisted surgery (RAS) devices for the better part of ...

Medtronic is expected to release its second-quarter results next month, and analysts project a single-digit earnings increase ...

The Minnesota medtech company’s Altaviva implant just secured FDA approval. It treats urinary urge incontinence, a ...

Cardiac mapper turned treatment of his own heart condition into a new career NORTHAMPTON, MA / ACCESS Newswire / November 3, 2025 / David Stalls thought the dangerous heart rhythm problem that plagued ...